Healthcare Sector Stocks
The Healthcare sector has a total of 1048 stocks, with a combined market cap of $9.31 trillion, total revenue of $4.67 trillion and a weighted average PE ratio of 49.25.
Market Cap
9.31T
Revenue
4.67T
Profits
189.01B
PE Ratio
49.25
Profit Margin
4.05%
Dividend Yield
0.38%
1048 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.04T | 0.45% | 2,454,096 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 648.72B | -0.10% | 5,682,967 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 468.66B | 0.28% | 2,766,250 | 64.39B |
| 4 | MRK | Merck & Co., Inc. | 372.32B | 0.94% | 11,172,989 | 66.57B |
| 5 | UNH | UnitedHealth Group Incorporated | 334.76B | -1.22% | 4,501,106 | 450.53B |
| 6 | NVS | Novartis AG | 269.50B | 0.21% | 1,543,989 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 262.23B | 0.16% | 2,306,242 | 61.37B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 243.49B | -0.04% | 2,105,426 | 46.34B |
| 9 | AMGN | Amgen Inc. | 221.79B | 4.34% | 3,720,319 | 38.10B |
| 10 | GILD | Gilead Sciences, Inc. | 189.30B | 1.40% | 5,082,413 | 30.46B |
| 11 | ABT | Abbott Laboratories | 179.42B | 0.69% | 8,383,323 | 46.59B |
| 12 | NVO | Novo Nordisk A/S | 175.17B | -1.01% | 24,463,070 | 50.34B |
| 13 | PFE | Pfizer Inc. | 159.19B | 0.68% | 26,669,292 | 63.70B |
| 14 | DHR | Danaher Corporation | 155.42B | 2.43% | 4,637,101 | 25.11B |
| 15 | ISRG | Intuitive Surgical, Inc. | 142.05B | 0.11% | 1,864,348 | 11.03B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 130.53B | 0.84% | 1,386,591 | 12.59B |
| 17 | BMY | Bristol-Myers Squibb Company | 127.16B | -0.59% | 15,237,705 | 49.19B |
| 18 | MDT | Medtronic plc | 116.11B | -1.07% | 14,190,355 | 37.54B |
| 19 | CVS | CVS Health Corporation | 111.40B | -0.57% | 8,711,925 | 412.65B |
| 20 | SYK | Stryker Corporation | 105.52B | 0.33% | 2,364,834 | 25.84B |
| 21 | MCK | McKesson Corporation | 103.91B | 0.54% | 935,662 | 410.98B |
| 22 | SNY | Sanofi | 101.98B | 0.02% | 3,069,564 | 55.89B |
| 23 | GSK | GSK plc | 101.90B | -0.70% | 4,296,165 | 44.05B |
| 24 | HCA | HCA Healthcare, Inc. | 94.85B | 2.85% | 1,502,774 | 78.01B |
| 25 | ELV | Elevance Health, Inc. | 87.27B | -1.68% | 1,117,186 | 201.11B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 80.27B | 0.72% | 598,050 | 15.53B |
| 27 | MRNA | Moderna, Inc. | 72.88B | 5.56% | 24,033,889 | 2.23B |
| 28 | CI | The Cigna Group | 72.33B | -0.27% | 1,468,881 | 282.38B |
| 29 | BSX | Boston Scientific Corporation | 65.10B | 2.74% | 21,082,686 | 21.00B |
| 30 | ARGX | argenx SE | 61.21B | -2.47% | 304,382 | 5.32B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 60.71B | 0.32% | 1,403,854 | 28.42B |
| 32 | COR | Cencora, Inc. | 60.00B | -0.65% | 775,712 | 332.77B |
| 33 | NTRA | Natera, Inc. | 56.35B | 5.47% | 1,520,107 | 2.71B |
| 34 | CAH | Cardinal Health, Inc. | 51.42B | -1.64% | 2,775,813 | 254.25B |
| 35 | EW | Edwards Lifesciences Corporation | 51.17B | 0.50% | 3,533,999 | 6.51B |
| 36 | BDX | Becton, Dickinson and Company | 49.85B | 1.27% | 1,461,160 | 22.48B |
| 37 | A | Agilent Technologies, Inc. | 47.16B | 3.29% | 3,782,902 | 7.37B |
| 38 | TEVA | Teva Pharmaceutical Industries Limited | 46.05B | -1.35% | 4,542,855 | 17.32B |
| 39 | MDLN | Medline Inc. | 45.27B | 7.73% | 10,320,097 | 29.94B |
| 40 | HUM | Humana Inc. | 44.67B | -1.74% | 858,106 | 145.68B |
| 41 | IQV | IQVIA Holdings Inc. | 44.46B | 0.08% | 950,723 | 16.98B |
| 42 | VEEV | Veeva Systems Inc. | 42.24B | -0.15% | 1,818,895 | 3.46B |
| 43 | ONC | BeOne Medicines AG | 41.85B | 0.66% | 262,916 | 6.13B |
| 44 | WAT | Waters Corporation | 41.83B | 0.43% | 648,347 | 4.64B |
| 45 | RVMD | Revolution Medicines, Inc. | 41.34B | 0.05% | 1,874,481 | - |
| 46 | IDXX | IDEXX Laboratories, Inc. | 41.08B | 1.20% | 476,529 | 4.55B |
| 47 | HLN | Haleon plc | 40.26B | -1.18% | 29,491,415 | 14.80B |
| 48 | ILMN | Illumina, Inc. | 37.37B | 3.62% | 2,642,136 | 4.49B |
| 49 | DXCM | DexCom, Inc. | 33.79B | 0.40% | 7,274,594 | 4.97B |
| 50 | ALNY | Alnylam Pharmaceuticals, Inc. | 33.67B | 3.00% | 1,131,865 | 4.80B |
| 51 | RPRX | Royalty Pharma plc | 33.65B | 0.14% | 2,683,119 | 2.54B |
| 52 | BIIB | Biogen Inc. | 33.30B | 2.87% | 1,111,836 | 10.03B |
| 53 | RMD | ResMed Inc. | 31.76B | -0.73% | 1,030,523 | 5.65B |
| 54 | ALC | Alcon Inc. | 31.64B | 1.11% | 947,684 | 10.86B |
| 55 | CNC | Centene Corporation | 31.27B | -2.60% | 6,104,427 | 180.30B |
| 56 | ZTS | Zoetis Inc. | 30.11B | 2.14% | 3,840,674 | 9.53B |
| 57 | GEHC | GE HealthCare Technologies Inc. | 29.93B | 2.25% | 3,941,731 | 21.27B |
| 58 | MTD | Mettler-Toledo International Inc. | 29.87B | 4.22% | 302,045 | 4.13B |
| 59 | ROIV | Roivant Sciences Ltd. | 27.61B | -1.97% | 6,716,850 | 7.53M |
| 60 | INSM | Insmed Incorporated | 26.38B | -0.15% | 2,404,983 | 1.14B |
| 61 | WST | West Pharmaceutical Services, Inc. | 26.12B | 2.57% | 734,698 | 3.33B |
| 62 | DGX | Quest Diagnostics Incorporated | 25.91B | -4.13% | 2,719,233 | 11.56B |
| 63 | INCY | Incyte Corporation | 25.73B | 1.83% | 1,647,166 | 5.82B |
| 64 | BNTX | BioNTech SE | 25.34B | 2.93% | 1,050,807 | 3.03B |
| 65 | LH | Labcorp Holdings Inc. | 25.27B | -2.94% | 1,912,179 | 14.35B |
| 66 | PHG | Koninklijke Philips N.V. | 24.44B | 0.28% | 568,410 | 20.18B |
| 67 | GH | Guardant Health, Inc. | 23.77B | 1.89% | 2,212,882 | 1.18B |
| 68 | UTHR | United Therapeutics Corporation | 21.34B | 0.91% | 586,396 | 3.15B |
| 69 | THC | Tenet Healthcare Corporation | 21.10B | 0.42% | 782,253 | 21.81B |
| 70 | GMAB | Genmab A/S | 20.84B | 1.53% | 2,297,572 | 4.13B |
| 71 | STE | STERIS plc | 20.36B | 0.88% | 624,627 | 6.04B |
| 72 | VTRS | Viatris Inc. | 19.73B | 0.47% | 5,238,439 | 14.74B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 17.93B | -0.36% | 1,706,314 | 8.51B |
| 74 | MEDP | Medpace Holdings, Inc. | 17.59B | 0.96% | 304,196 | 2.78B |
| 75 | RVTY | Revvity, Inc. | 15.99B | -0.19% | 2,871,258 | 2.91B |
| 76 | JAZZ | Jazz Pharmaceuticals plc | 15.62B | -0.37% | 482,009 | 4.60B |
| 77 | ASND | Ascendis Pharma A/S | 15.60B | -0.01% | 548,295 | 1.20B |
| 78 | SOLV | Solventum Corporation | 15.11B | -0.10% | 651,294 | 8.31B |
| 79 | NBIX | Neurocrine Biosciences, Inc. | 14.46B | -1.19% | 1,213,787 | 3.37B |
| 80 | EXEL | Exelixis, Inc. | 14.41B | 1.63% | 1,859,953 | 2.44B |
| 81 | TEM | Tempus AI, Inc. | 13.93B | -1.08% | 5,998,168 | 1.43B |
| 82 | SMMT | Summit Therapeutics Inc. | 13.66B | 1.30% | 4,578,970 | - |
| 83 | CRL | Charles River Laboratories International, Inc. | 13.61B | 2.19% | 1,137,106 | 4.00B |
| 84 | BBIO | BridgeBio Pharma, Inc. | 13.53B | 3.98% | 3,782,987 | 713.07M |
| 85 | HALO | Halozyme Therapeutics, Inc. | 13.07B | 3.30% | 4,151,097 | 1.66B |
| 86 | ICLR | ICON Public Limited Company | 12.89B | -1.44% | 1,056,002 | 8.29B |
| 87 | CORT | Corcept Therapeutics Incorporated | 12.70B | 3.29% | 810,211 | 830.81M |
| 88 | PEN | Penumbra, Inc. | 12.58B | 0.19% | 797,920 | 1.50B |
| 89 | BMRN | BioMarin Pharmaceutical Inc. | 12.27B | -1.08% | 1,962,097 | 3.41B |
| 90 | BAX | Baxter International Inc. | 12.24B | 3.27% | 7,364,165 | 11.47B |
| 91 | EHC | Encompass Health Corporation | 12.11B | 0.99% | 1,138,044 | 6.21B |
| 92 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.99B | -0.60% | 266,056 | 1.28B |
| 93 | FMS | Fresenius Medical Care AG | 11.92B | 1.26% | 954,277 | 22.19B |
| 94 | BTSG | BrightSpring Health Services, Inc. | 11.78B | 1.24% | 2,075,039 | 14.37B |
| 95 | DVA | DaVita Inc. | 11.72B | 0.76% | 552,634 | 14.01B |
| 96 | SNN | Smith & Nephew plc | 11.57B | -0.69% | 897,679 | 6.30B |
| 97 | ELAN | Elanco Animal Health Incorporated | 11.46B | 2.23% | 5,608,851 | 5.02B |
| 98 | TECH | Bio-Techne Corporation | 11.38B | 0.11% | 3,422,803 | 1.22B |
| 99 | ALGN | Align Technology, Inc. | 10.89B | 4.36% | 940,060 | 4.14B |
| 100 | AXSM | Axsome Therapeutics, Inc. | 10.64B | -1.16% | 299,543 | 776.57M |
| 101 | UHS | Universal Health Services, Inc. | 10.57B | 2.60% | 797,685 | 18.11B |
| 102 | RDY | Dr. Reddy's Laboratories Limited | 10.56B | 1.37% | 3,093,859 | 3.50B |
| 103 | RGEN | Repligen Corporation | 10.54B | 3.34% | 1,157,771 | 785.10M |
| 104 | TXG | 10x Genomics, Inc. | 10.51B | 2.02% | 3,890,608 | 616.91M |
| 105 | COO | The Cooper Companies, Inc. | 10.51B | 2.16% | 2,693,650 | 4.24B |
| 106 | KRYS | Krystal Biotech, Inc. | 10.39B | 5.10% | 274,520 | 440.48M |
| 107 | TWST | Twist Bioscience Corporation | 10.32B | -0.74% | 2,314,630 | 431.80M |
| 108 | ENSG | The Ensign Group, Inc. | 10.19B | 1.06% | 428,713 | 5.49B |
| 109 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.15B | 4.46% | 3,115,924 | 669.50M |
| 110 | KYMR | Kymera Therapeutics, Inc. | 10.15B | 3.73% | 779,350 | 105.00M |
| 111 | BIO | Bio-Rad Laboratories, Inc. | 10.15B | 0.59% | 374,681 | 2.59B |
| 112 | AVTR | Avantor, Inc. | 10.10B | -1.06% | 11,164,117 | 6.56B |
| 113 | GMED | Globus Medical, Inc. | 10.10B | 1.21% | 1,927,593 | 3.14B |
| 114 | MOH | Molina Healthcare, Inc. | 9.96B | -3.34% | 525,630 | 42.47B |
| 115 | IBRX | ImmunityBio, Inc. | 9.85B | 9.94% | 21,133,175 | 165.79M |
| 116 | HSIC | Henry Schein, Inc. | 9.74B | 2.62% | 1,062,473 | 13.60B |
| 117 | PODD | Insulet Corporation | 9.67B | -0.82% | 1,241,896 | 3.05B |
| 118 | OSCR | Oscar Health, Inc. | 9.46B | -1.98% | 8,244,785 | 15.32B |
| 119 | GKOS | Glaukos Corporation | 9.42B | -1.03% | 1,102,378 | 612.84M |
| 120 | CYTK | Cytokinetics, Incorporated | 9.40B | 0.04% | 2,368,280 | 67.67M |
| 121 | PTGX | Protagonist Therapeutics, Inc. | 9.39B | 0.06% | 793,834 | 281.99M |
| 122 | BRKR | Bruker Corporation | 9.33B | -0.60% | 1,981,600 | 3.50B |
| 123 | QGEN | Qiagen N.V. | 9.04B | -2.43% | 1,445,742 | 2.10B |
| 124 | CAI | Caris Life Sciences, Inc. | 8.89B | 2.68% | 5,959,729 | 989.61M |
| 125 | PCVX | Vaxcyte, Inc. | 8.78B | 0.17% | 1,278,880 | - |
| 126 | ABVX | ABIVAX Société Anonyme | 8.62B | -4.99% | 2,531,370 | 5.33M |
| 127 | PRAX | Praxis Precision Medicines, Inc. | 8.39B | 0.60% | 568,692 | 7.46M |
| 128 | TGTX | TG Therapeutics, Inc. | 8.24B | 1.66% | 2,084,473 | 799.54M |
| 129 | SYRE | Spyre Therapeutics, Inc. | 8.11B | -0.07% | 1,223,361 | - |
| 130 | ATR | AptarGroup, Inc. | 7.98B | 1.66% | 417,719 | 3.93B |
| 131 | IMVT | Immunovant, Inc. | 7.70B | 0.30% | 1,824,106 | - |
| 132 | IONS | Ionis Pharmaceuticals, Inc. | 7.60B | 1.89% | 4,466,724 | 874.09M |
| 133 | HNGE | Hinge Health, Inc. | 7.60B | -0.32% | 1,327,945 | 720.06M |
| 134 | HQY | HealthEquity, Inc. | 7.59B | -2.93% | 1,220,630 | 1.36B |
| 135 | ALKS | Alkermes plc | 7.26B | -2.01% | 2,310,671 | 1.67B |
| 136 | HIMS | Hims & Hers Health, Inc. | 7.10B | 3.68% | 16,648,708 | 2.58B |
| 137 | BLTE | Belite Bio, Inc | 7.06B | 1.12% | 204,649 | - |
| 138 | CGON | CG Oncology, Inc. | 6.89B | -0.65% | 1,641,911 | 6.23M |
| 139 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.83B | 0.45% | 478,652 | 239.92M |
| 140 | AMRX | Amneal Pharmaceuticals, Inc. | 6.79B | -3.27% | 2,481,261 | 3.12B |
| 141 | GRFS | Grifols, S.A. | 6.60B | 1.09% | 600,099 | 8.48B |
| 142 | PACS | PACS Group, Inc. | 6.58B | -1.26% | 812,181 | 5.55B |
| 143 | LNTH | Lantheus Holdings, Inc. | 6.53B | -0.28% | 1,519,726 | 1.56B |
| 144 | CHE | Chemed Corporation | 6.46B | -0.60% | 132,258 | 2.60B |
| 145 | ORKA | Oruka Therapeutics, Inc. | 6.26B | 1.25% | 1,055,115 | - |
| 146 | SRRK | Scholar Rock Holding Corporation | 6.23B | 6.29% | 3,748,521 | - |
| 147 | BLCO | Bausch + Lomb Corporation | 6.19B | 3.10% | 277,203 | 5.32B |
| 148 | LQDA | Liquidia Corporation | 6.14B | 3.33% | 1,109,313 | 450.91M |
| 149 | KNSA | Kiniksa Pharmaceuticals International, plc | 6.09B | -0.17% | 403,825 | 840.85M |
| 150 | MMED | MiniMed Group, Inc. | 5.96B | 0.38% | 2,803,837 | 3.22B |
| 151 | LGND | Ligand Pharmaceuticals Incorporated | 5.95B | 2.91% | 308,733 | 290.54M |
| 152 | MIRM | Mirum Pharmaceuticals, Inc. | 5.93B | -0.66% | 763,778 | 618.07M |
| 153 | STVN | Stevanato Group S.p.A. | 5.93B | 0.88% | 217,438 | 1.40B |
| 154 | RDNT | RadNet, Inc. | 5.82B | 1.73% | 790,915 | 2.27B |
| 155 | CRSP | CRISPR Therapeutics AG | 5.71B | 1.20% | 2,083,466 | 13.39M |
| 156 | TVTX | Travere Therapeutics, Inc. | 5.68B | -4.10% | 3,120,074 | 591.33M |
| 157 | COGT | Cogent Biosciences, Inc. | 5.66B | 1.97% | 2,035,933 | - |
| 158 | PTCT | PTC Therapeutics, Inc. | 5.51B | 1.07% | 1,296,978 | 1.01B |
| 159 | DNTH | Dianthus Therapeutics, Inc. | 5.50B | 1.95% | 1,126,834 | 1.90M |
| 160 | BLLN | BillionToOne, Inc. | 5.48B | 11.76% | 1,119,823 | 397.41M |
| 161 | ERAS | Erasca, Inc. | 5.44B | 3.39% | 4,766,263 | - |
| 162 | DFTX | Definium Therapeutics, Inc. | 5.42B | 2.65% | 1,753,154 | - |
| 163 | SHC | Sotera Health Company | 5.33B | -0.05% | 1,497,510 | 1.22B |
| 164 | TFX | Teleflex Incorporated | 5.29B | 0.08% | 777,134 | 2.25B |
| 165 | MMSI | Merit Medical Systems, Inc. | 5.21B | 2.07% | 682,773 | 1.58B |
| 166 | HAE | Haemonetics Corporation | 4.94B | -0.19% | 446,600 | 1.35B |
| 167 | MANE | Veradermics, Incorporated | 4.94B | 4.73% | 2,137,132 | - |
| 168 | WAY | Waystar Holding Corp. | 4.91B | -0.31% | 1,479,791 | 1.21B |
| 169 | GRAL | GRAIL, Inc. | 4.85B | 0.51% | 3,260,608 | 165.26M |
| 170 | EWTX | Edgewise Therapeutics, Inc. | 4.83B | -0.29% | 2,091,253 | - |
| 171 | IOVA | Iovance Biotherapeutics, Inc. | 4.82B | 4.42% | 16,058,115 | 324.97M |
| 172 | LFST | LifeStance Health Group, Inc. | 4.80B | -0.95% | 4,044,574 | 1.58B |
| 173 | VKTX | Viking Therapeutics, Inc. | 4.77B | 35.67% | 41,227,643 | - |
| 174 | DOCS | Doximity, Inc. | 4.73B | -1.23% | 2,407,514 | 655.57M |
| 175 | PBLS | Parabilis Medicines, Inc. | 4.72B | 3.36% | 863,611 | 148.00K |
| 176 | ACAD | ACADIA Pharmaceuticals Inc. | 4.55B | 0.04% | 1,442,433 | 1.14B |
| 177 | ADPT | Adaptive Biotechnologies Corporation | 4.48B | 0.72% | 3,999,697 | 308.08M |
| 178 | CON | Concentra Group Holdings Parent, Inc. | 4.45B | 0.32% | 681,264 | 2.29B |
| 179 | HTFL | HeartFlow, Inc. | 4.36B | -0.32% | 1,349,343 | 212.07M |
| 180 | LIVN | LivaNova PLC | 4.32B | 0.41% | 640,422 | 1.47B |
| 181 | TNGX | Tango Therapeutics, Inc. | 4.30B | 14.33% | 6,968,662 | 53.81M |
| 182 | ITGR | Integer Holdings Corporation | 4.29B | -0.04% | 555,049 | 1.84B |
| 183 | INDV | Indivior Pharmaceuticals, Inc. | 4.27B | 1.86% | 2,216,026 | 1.33B |
| 184 | RLAY | Relay Therapeutics, Inc. | 4.24B | 6.38% | 3,610,077 | 10.35M |
| 185 | AMLX | Amylyx Pharmaceuticals, Inc. | 4.14B | 1.88% | 1,383,678 | -665.00K |
| 186 | CELC | Celcuity Inc. | 4.12B | 0.12% | 540,173 | - |
| 187 | ABCL | AbCellera Biologics Inc. | 4.10B | -0.08% | 4,285,265 | 66.17M |
| 188 | TLX | Telix Pharmaceuticals Limited | 4.05B | 5.66% | 613,708 | 890.79M |
| 189 | ICUI | ICU Medical, Inc. | 4.03B | 3.71% | 275,991 | 2.16B |
| 190 | NVST | Envista Holdings Corporation | 3.88B | 3.20% | 4,043,622 | 2.86B |
| 191 | IDYA | IDEAYA Biosciences, Inc. | 3.83B | 2.19% | 745,781 | 234.13M |
| 192 | XENE | Xenon Pharmaceuticals Inc. | 3.79B | 0.26% | 2,347,997 | 7.50M |
| 193 | PLSE | Pulse Biosciences, Inc. | 3.76B | -1.16% | 368,136 | 1.19M |
| 194 | IRTC | iRhythm Holdings, Inc. | 3.64B | 0.14% | 402,810 | 825.34M |
| 195 | LEGN | Legend Biotech Corporation | 3.61B | 0.59% | 2,308,506 | 1.27B |
| 196 | OGN | Organon & Co. | 3.60B | 0.15% | 1,365,156 | 6.13B |
| 197 | OPCH | Option Care Health, Inc. | 3.58B | -0.21% | 2,143,180 | 5.69B |
| 198 | ELVN | Enliven Therapeutics, Inc. | 3.53B | -1.39% | 1,212,691 | - |
| 199 | ARQT | Arcutis Biotherapeutics, Inc. | 3.49B | 7.01% | 2,857,702 | 463.98M |
| 200 | NHC | National HealthCare Corporation | 3.49B | -0.20% | 71,931 | 1.56B |
| 201 | VCYT | Veracyte, Inc. | 3.49B | 4.43% | 1,472,388 | 561.90M |
| 202 | DNLI | Denali Therapeutics Inc. | 3.45B | 5.52% | 2,336,642 | 3.60M |
| 203 | RCUS | Arcus Biosciences, Inc. | 3.42B | 3.55% | 1,385,194 | 117.00M |
| 204 | TARS | Tarsus Pharmaceuticals, Inc. | 3.38B | -0.49% | 517,013 | 606.33M |
| 205 | DYN | Dyne Therapeutics, Inc. | 3.20B | 0.12% | 2,626,765 | - |
| 206 | QURE | uniQure N.V. | 3.14B | 2.19% | 1,135,628 | 18.67M |
| 207 | RGC | Regencell Bioscience Holdings Limited | 3.09B | 5.24% | 126,362 | - |
| 208 | TMDX | TransMedics Group, Inc. | 3.05B | 0.89% | 743,475 | 668.47M |
| 209 | NEOG | Neogen Corporation | 3.05B | 2.72% | 4,573,779 | 870.40M |
| 210 | ATRC | AtriCure, Inc. | 2.99B | 0.87% | 872,569 | 569.62M |
| 211 | MBX | MBX Biosciences, Inc. | 2.98B | 1.71% | 433,327 | - |
| 212 | ZLAB | Zai Lab Limited | 2.96B | -0.08% | 996,556 | 449.61M |
| 213 | IMNM | Immunome, Inc. | 2.92B | 2.71% | 1,064,455 | 4.02M |
| 214 | CDNA | CareDx, Inc. | 2.92B | 3.98% | 1,991,547 | 458.09M |
| 215 | AVAH | Aveanna Healthcare Holdings Inc. | 2.88B | -1.64% | 3,115,777 | 2.60B |
| 216 | WRBY | Warby Parker Inc. | 2.84B | -1.33% | 3,643,478 | 911.61M |
| 217 | GRDN | Guardian Pharmacy Services, Inc. | 2.83B | 1.15% | 397,124 | 1.46B |
| 218 | PGEN | Precigen, Inc. | 2.82B | 2.47% | 5,304,896 | 85.72M |
| 219 | NAMS | NewAmsterdam Pharma Company N.V. | 2.79B | 3.28% | 2,868,733 | 7.12M |
| 220 | ACHC | Acadia Healthcare Company, Inc. | 2.73B | 3.52% | 1,810,446 | 3.37B |
| 221 | BKD | Brookdale Senior Living Inc. | 2.72B | 0.09% | 4,386,528 | 2.93B |
| 222 | WGS | GeneDx Holdings Corp. | 2.71B | -7.19% | 1,685,495 | 454.43M |
| 223 | NRIX | Nurix Therapeutics, Inc. | 2.66B | 1.02% | 1,509,496 | 36.77M |
| 224 | BFLY | Butterfly Network, Inc. | 2.64B | 21.99% | 19,819,021 | 112.14M |
| 225 | GPCR | Structure Therapeutics Inc. | 2.63B | 0.27% | 611,779 | - |
| 226 | CLDX | Celldex Therapeutics, Inc. | 2.63B | -11.56% | 12,888,683 | 158.00K |
| 227 | IRON | Disc Medicine, Inc. | 2.63B | -0.01% | 450,834 | - |
| 228 | AXGN | Axogen, Inc. | 2.61B | -3.03% | 1,331,570 | 251.17M |
| 229 | VERA | Vera Therapeutics, Inc. | 2.61B | 5.87% | 1,977,538 | - |
| 230 | MLYS | Mineralys Therapeutics, Inc. | 2.60B | 3.85% | 849,421 | - |
| 231 | BEAM | Beam Therapeutics Inc. | 2.59B | 2.65% | 1,988,492 | 156.04M |
| 232 | SUPN | Supernus Pharmaceuticals, Inc. | 2.54B | 2.27% | 667,552 | 830.44M |
| 233 | VRDN | Viridian Therapeutics, Inc. | 2.51B | 2.50% | 1,456,720 | 71.13M |
| 234 | PRVA | Privia Health Group, Inc. | 2.49B | -0.41% | 1,086,917 | 2.36B |
| 235 | HCM | HUTCHMED (China) Limited | 2.48B | -2.83% | 37,023 | 549.12M |
| 236 | CLOV | Clover Health Investments, Corp. | 2.48B | 2.86% | 4,516,994 | 2.48B |
| 237 | PHVS | Pharvaris N.V. | 2.47B | -2.28% | 587,005 | - |
| 238 | SLS | SELLAS Life Sciences Group, Inc. | 2.43B | 5.72% | 5,952,847 | - |
| 239 | NEO | NeoGenomics, Inc. | 2.43B | -2.68% | 4,000,536 | 766.30M |
| 240 | HRMY | Harmony Biosciences Holdings, Inc. | 2.42B | -1.35% | 577,915 | 959.90M |
| 241 | TRLV | Trulieve Cannabis Corp. | 2.40B | 8.43% | 3,252,232 | 1.14B |
| 242 | OCUL | Ocular Therapeutix, Inc. | 2.31B | 5.11% | 2,495,263 | 52.06M |
| 243 | ALMR | Alamar Biosciences, Inc. | 2.31B | -5.22% | 455,075 | 100.42M |
| 244 | SDGR | Schrödinger, Inc. | 2.30B | 1.52% | 2,565,902 | 259.04M |
| 245 | PVLA | Palvella Therapeutics, Inc. | 2.28B | 3.08% | 272,971 | - |
| 246 | PBH | Prestige Consumer Healthcare Inc. | 2.26B | 1.99% | 619,561 | 1.10B |
| 247 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.24B | 0.23% | 3,442,172 | 940.61M |
| 248 | BHVN | Biohaven Ltd. | 2.24B | 4.43% | 2,432,640 | - |
| 249 | GENB | Generate Biomedicines, Inc. | 2.24B | 0.46% | 1,306,264 | 26.48M |
| 250 | AUPH | Aurinia Pharmaceuticals Inc. | 2.22B | 0.36% | 884,929 | 311.51M |
| 251 | UFPT | UFP Technologies, Inc. | 2.21B | 1.25% | 91,625 | 631.64M |
| 252 | SRPT | Sarepta Therapeutics, Inc. | 2.20B | 3.33% | 2,193,201 | 1.97B |
| 253 | ADMA | ADMA Biologics, Inc. | 2.20B | 3.15% | 2,737,629 | 512.28M |
| 254 | BHC | Bausch Health Companies Inc. | 2.17B | 3.01% | 1,913,014 | 10.85B |
| 255 | RXRX | Recursion Pharmaceuticals, Inc. | 2.17B | 2.02% | 40,378,319 | 54.86M |
| 256 | TRVI | Trevi Therapeutics, Inc. | 2.17B | 2.35% | 1,232,816 | - |
| 257 | ZBIO | Zenas BioPharma, Inc. | 2.15B | 1.54% | 452,804 | 1.00M |
| 258 | NUVB | Nuvation Bio Inc. | 2.14B | 0.49% | 4,323,981 | 169.90M |
| 259 | KOD | Kodiak Sciences Inc. | 2.12B | 4.26% | 1,038,110 | - |
| 260 | ESTA | Establishment Labs Holdings Inc. | 2.09B | 3.69% | 281,093 | 245.82M |
| 261 | URGN | UroGen Pharma Ltd. | 2.09B | -1.02% | 394,645 | 188.73M |
| 262 | MD | Pediatrix Medical Group, Inc. | 2.09B | 2.25% | 817,963 | 1.95B |
| 263 | ADUS | Addus HomeCare Corporation | 2.09B | -0.97% | 154,475 | 1.48B |
| 264 | AGIO | Agios Pharmaceuticals, Inc. | 2.09B | 3.00% | 1,130,571 | 98.34M |
| 265 | ALVO | Alvotech | 2.08B | -0.68% | 978,059 | 494.61M |
| 266 | NKTR | Nektar Therapeutics | 2.08B | -8.78% | 3,318,121 | 54.59M |
| 267 | INSP | Inspire Medical Systems, Inc. | 2.06B | -5.84% | 1,122,093 | 898.74M |
| 268 | VCEL | Vericel Corporation | 2.06B | 1.69% | 546,840 | 306.30M |
| 269 | SGRY | Surgery Partners, Inc. | 2.05B | 15.67% | 8,154,093 | 3.37B |
| 270 | CMPS | COMPASS Pathways plc | 2.05B | -1.53% | 2,315,589 | - |
| 271 | PGNY | Progyny, Inc. | 2.01B | -2.31% | 879,312 | 1.31B |
| 272 | MESO | Mesoblast Limited | 1.99B | 2.84% | 198,533 | 120.25M |
| 273 | RAPP | Rapport Therapeutics, Inc. | 1.99B | 4.56% | 898,754 | 20.00M |
| 274 | PRGO | Perrigo Company plc | 1.99B | 1.27% | 2,322,378 | 4.14B |
| 275 | XRAY | DENTSPLY SIRONA Inc. | 1.98B | 5.40% | 5,133,731 | 3.64B |
| 276 | LKFT | Lakefront Biotherapeutics NV | 1.96B | 2.03% | 451,827 | 1.13B |
| 277 | ZYME | Zymeworks Inc. | 1.96B | 2.82% | 445,932 | 37.13M |
| 278 | VIR | Vir Biotechnology, Inc. | 1.95B | 5.70% | 1,852,419 | 303.23M |
| 279 | FTRE | Fortrea Holdings Inc. | 1.94B | 2.05% | 1,509,236 | 2.68B |
| 280 | NVCR | NovoCure Limited | 1.94B | 0.85% | 1,044,394 | 699.19M |
| 281 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.94B | 4.04% | 1,570,988 | 208.78M |
| 282 | GHRS | GH Research PLC | 1.91B | -0.25% | 101,538 | - |
| 283 | SEPN | Septerna, Inc. | 1.88B | 4.77% | 410,683 | 98.88M |
| 284 | STOK | Stoke Therapeutics, Inc. | 1.88B | 4.10% | 527,062 | 27.59M |
| 285 | XNCR | Xencor, Inc. | 1.87B | 0.52% | 1,223,601 | 104.97M |
| 286 | BLFS | BioLife Solutions, Inc. | 1.86B | 2.39% | 824,997 | 106.69M |
| 287 | LMAT | LeMaitre Vascular, Inc. | 1.85B | 2.25% | 260,932 | 262.43M |
| 288 | ABSI | Absci Corporation | 1.84B | 9.06% | 8,366,973 | 1.56M |
| 289 | SNDA | Sonida Senior Living, Inc. | 1.81B | - | 353,315 | 481.07M |
| 290 | ASTH | Astrana Health, Inc. | 1.80B | 4.65% | 409,413 | 3.84B |
| 291 | COAG | Hemab Therapeutics Holdings, Inc. | 1.79B | 0.74% | 550,078 | - |
| 292 | NVAX | Novavax, Inc. | 1.79B | 4.03% | 7,580,003 | 413.80M |
| 293 | NTLA | Intellia Therapeutics, Inc. | 1.78B | 3.85% | 3,921,329 | 59.51M |
| 294 | FRNM | Freenome, Inc. | 1.77B | -0.87% | 567,950 | 35.41M |
| 295 | TYRA | Tyra Biosciences, Inc. | 1.76B | -0.31% | 1,215,856 | - |
| 296 | NBTX | Nanobiotix S.A. | 1.76B | 2.68% | 44,015 | 38.27M |
| 297 | PSNL | Personalis, Inc. | 1.75B | 0.74% | 1,358,952 | 69.67M |
| 298 | TSHA | Taysha Gene Therapies, Inc. | 1.68B | 2.38% | 2,305,665 | 5.49M |
| 299 | IMCR | Immunocore Holdings plc | 1.67B | 0.75% | 282,054 | 430.78M |
| 300 | ANIP | ANI Pharmaceuticals, Inc. | 1.67B | -1.19% | 451,877 | 978.38M |
| 301 | KLRA | Kailera Therapeutics, Inc. | 1.66B | 6.67% | 1,229,954 | - |
| 302 | ALHC | Alignment Healthcare, Inc. | 1.66B | -4.08% | 11,961,555 | 4.58B |
| 303 | ETON | Eton Pharmaceuticals, Inc. | 1.63B | 3.22% | 464,598 | 105.60M |
| 304 | INBX | Inhibrx Biosciences, Inc. | 1.63B | -1.22% | 292,112 | 1.30M |
| 305 | SNDX | Syndax Pharmaceuticals, Inc. | 1.62B | 0.64% | 1,667,761 | 252.25M |
| 306 | ANAB | AnaptysBio, Inc. | 1.61B | -1.82% | 755,710 | 106.09M |
| 307 | ATEC | Alphatec Holdings, Inc. | 1.60B | 1.57% | 1,207,743 | 815.05M |
| 308 | KRSA | Korsana Biosciences, Inc. | 1.59B | 5.33% | 26,615 | - |
| 309 | XERS | Xeris Biopharma Holdings, Inc. | 1.59B | -0.80% | 1,689,197 | 335.41M |
| 310 | MAZE | Maze Therapeutics, Inc. | 1.58B | 26.75% | 3,568,200 | 20.00M |
| 311 | KMTS | Kestra Medical Technologies, Ltd. | 1.55B | 5.33% | 281,551 | 106.73M |
| 312 | ARDT | Ardent Health, Inc. | 1.54B | 3.20% | 504,168 | 6.41B |
| 313 | KARD | Kardigan, Inc. | 1.54B | 0.86% | 598,209 | - |
| 314 | RARE | Ultragenyx Pharmaceutical Inc. | 1.53B | 6.59% | 8,112,904 | 717.00M |
| 315 | OMER | Omeros Corporation | 1.52B | 13.85% | 3,958,754 | 38.42M |
| 316 | INVA | Innoviva, Inc. | 1.52B | -0.29% | 931,641 | 440.00M |
| 317 | BRVE | Braveheart Bio, Inc. | 1.52B | -5.64% | 829,452 | - |
| 318 | OMCL | Omnicell, Inc. | 1.51B | 2.28% | 547,164 | 1.25B |
| 319 | BCAX | Bicara Therapeutics Inc. | 1.51B | 3.50% | 622,055 | - |
| 320 | AZTA | Azenta, Inc. | 1.50B | 1.57% | 1,131,869 | 613.81M |
| 321 | AVBP | ArriVent BioPharma, Inc. | 1.50B | 1.95% | 389,080 | - |
| 322 | HCSG | Healthcare Services Group, Inc. | 1.48B | 1.27% | 1,422,638 | 1.86B |
| 323 | AAPG | Ascentage Pharma Group International | 1.47B | 0.06% | 823 | 94.61M |
| 324 | TRAX | First Tracks Biotherapeutics, Inc. | 1.47B | 5.23% | 893,138 | - |
| 325 | AGL | agilon health, inc. | 1.46B | -1.35% | 285,956 | 5.92B |
| 326 | INNV | InnovAge Holding Corp. | 1.45B | 0.52% | 339,081 | 989.71M |
| 327 | AVLN | Avalyn Pharma Inc. | 1.44B | 2.62% | 233,277 | - |
| 328 | NUTX | Nutex Health Inc. | 1.43B | 3.64% | 158,194 | 846.72M |
| 329 | PAHC | Phibro Animal Health Corporation | 1.43B | 1.36% | 169,072 | 1.52B |
| 330 | ORIC | ORIC Pharmaceuticals, Inc. | 1.40B | 6.55% | 1,157,516 | - |
| 331 | DRTS | Alpha Tau Medical Ltd. | 1.40B | -2.32% | 360,285 | - |
| 332 | CGEM | Cullinan Therapeutics, Inc. | 1.39B | 1.50% | 831,774 | - |
| 333 | DMRA | Damora Therapeutics, Inc. | 1.38B | -1.93% | 354,904 | - |
| 334 | CNMD | CONMED Corporation | 1.38B | 3.31% | 441,782 | 1.37B |
| 335 | LTGO | Latigo Biotherapeutics, Inc. | 1.38B | -1.37% | 418,233 | - |
| 336 | LBRX | LB Pharmaceuticals Inc | 1.38B | -0.70% | 244,389 | - |
| 337 | PNTG | The Pennant Group, Inc. | 1.38B | 1.16% | 232,149 | 1.10B |
| 338 | SVRA | Savara Inc. | 1.35B | -2.75% | 1,413,964 | - |
| 339 | CERT | Certara, Inc. | 1.35B | 3.64% | 2,321,585 | 421.75M |
| 340 | AMN | AMN Healthcare Services, Inc. | 1.34B | 0.88% | 451,641 | 3.43B |
| 341 | OMDA | Omada Health, Inc. | 1.31B | 3.69% | 1,316,439 | 309.76M |
| 342 | VOR | Vor Biopharma Inc. | 1.30B | 0.50% | 2,586,519 | - |
| 343 | HROW | Harrow, Inc. | 1.29B | 1.56% | 428,339 | 275.59M |
| 344 | OPK | OPKO Health, Inc. | 1.29B | 2.37% | 3,477,510 | 587.90M |
| 345 | REPL | Replimune Group, Inc. | 1.27B | 4.66% | 1,522,105 | - |
| 346 | CRON | Cronos Group Inc. | 1.26B | 3.00% | 768,478 | 179.09M |
| 347 | IART | Integra LifeSciences Holdings Corporation | 1.25B | 2.76% | 770,363 | 1.65B |
| 348 | USPH | U.S. Physical Therapy, Inc. | 1.24B | 0.87% | 217,021 | 804.27M |
| 349 | AKTS | Aktis Oncology, Inc. | 1.23B | 3.17% | 301,664 | 10.06M |
| 350 | TNDM | Tandem Diabetes Care, Inc. | 1.22B | -0.68% | 2,688,073 | 1.04B |
| 351 | IMTX | Immatics N.V. | 1.21B | 1.72% | 501,597 | 47.65M |
| 352 | ANRO | Alto Neuroscience, Inc. | 1.21B | 0.49% | 347,072 | - |
| 353 | BBNX | Beta Bionics, Inc. | 1.20B | 3.49% | 999,194 | 119.01M |
| 354 | SPTX | Seaport Therapeutics, Inc. | 1.20B | 6.01% | 146,193 | - |
| 355 | MGTX | MeiraGTx Holdings plc | 1.19B | -5.58% | 1,439,305 | 397.50M |
| 356 | AORT | Artivion, Inc. | 1.18B | 2.12% | 605,482 | 471.47M |
| 357 | GDRX | GoodRx Holdings, Inc. | 1.17B | 1.47% | 912,064 | 785.23M |
| 358 | TDOC | Teladoc Health, Inc. | 1.15B | 1.28% | 2,988,390 | 2.49B |
| 359 | BVS | Bioventus Inc. | 1.15B | 2.55% | 429,315 | 581.85M |
| 360 | MLTX | MoonLake Immunotherapeutics | 1.14B | 6.61% | 2,361,986 | - |
| 361 | CRVS | Corvus Pharmaceuticals, Inc. | 1.13B | 8.21% | 806,552 | - |
| 362 | MNKD | MannKind Corporation | 1.12B | -0.29% | 16,303,712 | 393.63M |
| 363 | ODTX | Odyssey Therapeutics, Inc. | 1.12B | 1.21% | 555,204 | 99.00K |
| 364 | IRMD | IRADIMED CORPORATION | 1.11B | 4.91% | 176,501 | 86.34M |
| 365 | GLUE | Monte Rosa Therapeutics, Inc. | 1.07B | 2.77% | 1,212,917 | 28.73M |
| 366 | ANL | Adlai Nortye Group Ltd. | 1.07B | 6.62% | 107,179 | 18.06M |
| 367 | JANX | Janux Therapeutics, Inc. | 1.07B | 2.70% | 826,060 | 24.00M |
| 368 | JBIO | Jade Biosciences, Inc. | 1.07B | 0.12% | 643,918 | - |
| 369 | CSTL | Castle Biosciences, Inc. | 1.06B | -0.40% | 430,977 | 357.28M |
| 370 | APMD | Apnimed, Inc. | 1.06B | -2.71% | 624,115 | 115.12M |
| 371 | ENOV | Enovis Corporation | 1.06B | 1.94% | 1,790,972 | 2.30B |
| 372 | PRCT | PROCEPT BioRobotics Corporation | 1.06B | -0.43% | 1,167,982 | 337.34M |
| 373 | OBX | Obsidian Therapeutics, Inc. | 1.05B | -1.90% | 1,151,576 | - |
| 374 | ALMS | Alumis Inc. | 1.05B | 2.66% | 2,524,704 | 7.40M |
| 375 | KURA | Kura Oncology, Inc. | 1.04B | 1.12% | 1,673,992 | 77.23M |
| 376 | STAA | STAAR Surgical Company | 1.04B | 1.62% | 751,106 | 339.59M |
| 377 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.03B | -0.65% | 497,676 | 730.02M |
| 378 | LMRI | Lumexa Imaging Holdings, Inc. | 1.01B | -1.50% | 658,670 | 1.04B |
| 379 | HELP | Cybin Inc. | 1.00B | 0.37% | 2,427,671 | - |
| 380 | SANA | Sana Biotechnology, Inc. | 996.87M | 7.42% | 7,119,257 | - |
| 381 | ABUS | Arbutus Biopharma Corporation | 991.22M | 0.20% | 10,494,036 | 181.72M |
| 382 | PCRX | Pacira BioSciences, Inc. | 984.59M | 2.45% | 378,542 | 746.16M |
| 383 | LXRX | Lexicon Pharmaceuticals, Inc. | 970.00M | 6.86% | 4,843,763 | 41.47M |
| 384 | SGP | SpyGlass Pharma, Inc. | 959.62M | 2.61% | 170,766 | - |
| 385 | SLBT | SL Science Holding Limited | 958.05M | -2.33% | 27,249 | 3.27M |
| 386 | SLDB | Solid Biosciences Inc. | 956.45M | 4.45% | 1,293,964 | - |
| 387 | ATTO | Attovia Therapeutics, Inc. | 946.81M | -2.63% | 317,687 | 1.80M |
| 388 | CBLL | CeriBell, Inc. | 930.67M | - | 349,786 | 101.96M |
| 389 | IMMX | Immix Biopharma, Inc. | 917.85M | 2.89% | 948,477 | - |
| 390 | RIGL | Rigel Pharmaceuticals, Inc. | 911.95M | 3.67% | 242,361 | 276.79M |
| 391 | CADL | Candel Therapeutics, Inc. | 906.74M | 5.71% | 882,043 | - |
| 392 | ARDX | Ardelyx, Inc. | 902.06M | 3.43% | 3,988,929 | 450.89M |
| 393 | HSTM | HealthStream, Inc. | 887.59M | -0.24% | 128,210 | 321.12M |
| 394 | AVTX | Avalo Therapeutics, Inc. | 885.43M | 2.10% | 585,526 | 59.00K |
| 395 | TBPH | Theravance Biopharma, Inc. | 884.18M | -0.12% | 6,187,418 | 104.31M |
| 396 | GMRS | GMR Solutions Inc. | 879.03M | -2.08% | 1,017,634 | 5.88B |
| 397 | FDMT | 4D Molecular Therapeutics, Inc. | 877.28M | 4.20% | 936,947 | 92.01M |
| 398 | FTH | Faeth Therapeutics, Inc. | 863.07M | 0.33% | 632,956 | - |
| 399 | WVE | Wave Life Sciences, Inc. | 857.16M | 2.23% | 2,578,109 | 65.37M |
| 400 | ETRA | Electra Therapeutics, Inc. | 854.89M | -2.16% | 439,689 | - |
| 401 | OLMA | Olema Pharmaceuticals, Inc. | 843.48M | 0.10% | 1,490,426 | - |
| 402 | SIBN | SI-BONE, Inc. | 843.04M | 1.95% | 448,165 | 213.60M |
| 403 | ACRS | Aclaris Therapeutics, Inc. | 841.98M | 2.69% | 2,879,386 | 8.22M |
| 404 | GERN | Geron Corporation | 841.64M | 0.77% | 6,215,136 | 204.56M |
| 405 | ACHV | Achieve Life Sciences, Inc. | 835.57M | 0.87% | 1,674,733 | - |
| 406 | INMD | InMode Ltd. | 830.60M | -0.34% | 308,797 | 374.63M |
| 407 | IVA | Inventiva S.A. | 828.70M | - | 2,556,129 | 7.94M |
| 408 | DSGN | Design Therapeutics, Inc. | 823.57M | 4.86% | 506,521 | - |
| 409 | CLYM | Climb Bio, Inc. | 816.17M | 4.18% | 930,025 | - |
| 410 | GYRE | Gyre Therapeutics, Inc. | 794.19M | 0.81% | 227,129 | 109.82M |
| 411 | ANNX | Annexon, Inc. | 792.44M | -0.95% | 2,000,144 | - |
| 412 | AVR | Anteris Technologies Global Corp. | 792.34M | -0.25% | 842,895 | 2.24M |
| 413 | PHAR | Pharming Group N.V. | 781.08M | 4.16% | 51,291 | 366.48M |
| 414 | VREX | Varex Imaging Corporation | 778.89M | 0.05% | 687,730 | 865.00M |
| 415 | BLSM | BlossomHill Therapeutics, Inc. | 773.75M | -5.78% | 246,865 | - |
| 416 | AHCO | AdaptHealth Corp. | 769.77M | 0.35% | 2,580,326 | 3.36B |
| 417 | VSTM | Verastem, Inc. | 758.02M | 4.76% | 3,056,451 | 87.53M |
| 418 | GLAS | Glass House Brands Inc. | 754.88M | 0.88% | 1,243,851 | 176.98M |
| 419 | QDEL | QuidelOrtho Corporation | 750.22M | 0.74% | 1,151,004 | 2.67B |
| 420 | NVCT | Nuvectis Pharma, Inc. | 749.38M | 4.64% | 123,962 | - |
| 421 | IRWD | Ironwood Pharmaceuticals, Inc. | 747.71M | 2.61% | 3,427,917 | 389.32M |
| 422 | CTKB | Cytek Biosciences, Inc. | 742.20M | 8.14% | 3,779,423 | 206.71M |
| 423 | COLL | Collegium Pharmaceutical, Inc. | 741.62M | -1.13% | 808,250 | 808.21M |
| 424 | SLN | Silence Therapeutics plc | 739.97M | 0.33% | 381,900 | 615.00K |
| 425 | DBVT | DBV Technologies S.A. | 724.63M | 4.38% | 281,997 | 5.04M |
| 426 | MDXG | MiMedx Group, Inc. | 718.60M | 2.49% | 1,032,046 | 355.17M |
| 427 | STLN | Starling Oncology, Inc. | 718.51M | 3.22% | 1,050,937 | 587.24M |
| 428 | OABI | OmniAb, Inc. | 715.32M | 7.42% | 1,375,228 | 38.46M |
| 429 | CBIO | Crescent Biopharma, Inc. | 703.65M | 1.17% | 257,616 | 11.88M |
| 430 | SGMT | Sagimet Biosciences Inc. | 689.34M | 2.69% | 867,367 | - |
| 431 | ZVRA | Zevra Therapeutics, Inc. | 687.66M | -0.77% | 601,196 | 136.07M |
| 432 | SOPH | SOPHiA GENETICS SA | 686.98M | -2.06% | 564,641 | 86.17M |
| 433 | NGNE | Neurogene Inc. | 672.38M | 3.16% | 1,223,244 | 925.00K |
| 434 | AURA | Aura Biosciences, Inc. | 668.90M | 1.42% | 600,959 | - |
| 435 | ALT | Altimmune, Inc. | 663.31M | 4.28% | 4,003,284 | 31.00K |
| 436 | SSII | SS Innovations International, Inc. | 661.27M | 0.30% | 103,544 | 52.40M |
| 437 | OCS | Oculis Holding AG | 661.15M | 5.62% | 206,687 | 1.45M |
| 438 | STTK | Shattuck Labs, Inc. | 652.36M | 6.38% | 1,459,311 | 1.00M |
| 439 | MNPR | Monopar Therapeutics Inc. | 648.60M | 0.95% | 136,005 | - |
| 440 | ANGO | AngioDynamics, Inc. | 648.09M | 1.69% | 439,346 | 320.17M |
| 441 | CTMX | CytomX Therapeutics, Inc. | 640.62M | 6.52% | 7,922,964 | 18.30M |
| 442 | AHG | Akso Health Group | 634.05M | -2.62% | 1,106 | 13.83M |
| 443 | DNA | Ginkgo Bioworks Holdings, Inc. | 630.98M | 17.42% | 3,334,099 | 132.42M |
| 444 | PRME | Prime Medicine, Inc. | 629.78M | 10.97% | 2,710,416 | 4.07M |
| 445 | PHR | Phreesia, Inc. | 626.92M | 0.70% | 476,764 | 507.79M |
| 446 | AQST | Aquestive Therapeutics, Inc. | 621.28M | 3.56% | 2,481,868 | 54.09M |
| 447 | PHAT | Phathom Pharmaceuticals, Inc. | 616.38M | 4.16% | 1,951,566 | 239.66M |
| 448 | VALN | Valneva SE | 614.36M | -0.45% | 14,203 | 163.30M |
| 449 | DRUG | Bright Minds Biosciences Inc. | 607.73M | 2.03% | 65,235 | - |
| 450 | CRMD | CorMedix Inc. | 606.41M | 0.13% | 788,926 | 462.25M |
| 451 | MPLT | MapLight Therapeutics, Inc. | 603.55M | -0.37% | 411,295 | - |
| 452 | FLGT | Fulgent Genetics, Inc. | 595.71M | 0.51% | 252,194 | 323.93M |
| 453 | KIDS | OrthoPediatrics Corp. | 594.26M | 1.83% | 112,557 | 252.72M |
| 454 | ALLO | Allogene Therapeutics, Inc. | 590.79M | 1.18% | 5,237,474 | 4.64M |
| 455 | WEAV | Weave Communications, Inc. | 587.19M | 0.27% | 2,121,871 | 257.79M |
| 456 | TLRY | Tilray Brands, Inc. | 579.47M | 3.68% | 4,286,949 | 915.45M |
| 457 | EVO | Evotec SE | 570.73M | 2.60% | 126,936 | 819.47M |
| 458 | DCTH | Delcath Systems, Inc. | 569.06M | 1.80% | 368,615 | 95.42M |
| 459 | EPRX | Eupraxia Pharmaceuticals Inc. | 565.96M | -0.69% | 781,365 | - |
| 460 | AGMB | AgomAb Therapeutics NV | 565.86M | -1.79% | 49,390 | - |
| 461 | ARVN | Arvinas, Inc. | 556.44M | 2.53% | 685,165 | 316.70M |
| 462 | PROK | ProKidney Corp. | 553.25M | 3.10% | 579,649 | 818.00K |
| 463 | EOLS | Evolus, Inc. | 544.92M | 3.25% | 500,633 | 316.49M |
| 464 | CAPR | Capricor Therapeutics, Inc. | 543.02M | 4.94% | 2,499,553 | 11.13M |
| 465 | AUTL | Autolus Therapeutics plc | 540.31M | 4.64% | 1,569,961 | 117.39M |
| 466 | OVID | Ovid Therapeutics Inc. | 539.02M | 1.85% | 3,743,695 | 1.58M |
| 467 | BWAY | BrainsWay Ltd. | 538.81M | 0.44% | 190,829 | 60.70M |
| 468 | CERS | Cerus Corporation | 538.07M | 4.30% | 3,817,930 | 221.55M |
| 469 | RGNX | REGENXBIO Inc. | 538.01M | 3.43% | 1,194,703 | 174.48M |
| 470 | SENS | Senseonics Holdings, Inc. | 531.91M | 2.86% | 714,463 | 48.55M |
| 471 | INDP | Indaptus Therapeutics, Inc. | 531.64M | 29.13% | 1,264,582 | - |
| 472 | SCTX | Scribe Therapeutics Inc. | 531.41M | 0.07% | 582,144 | 33.30M |
| 473 | ASMB | Assembly Biosciences, Inc. | 518.18M | 0.04% | 1,070,096 | 74.85M |
| 474 | TECX | Tectonic Therapeutic, Inc. | 518.06M | -0.49% | 188,596 | - |
| 475 | ENTX | Entera Bio Ltd. | 515.96M | 0.68% | 613,718 | 42.00K |
| 476 | TCMD | Tactile Systems Technology, Inc. | 513.75M | -0.74% | 296,995 | 350.31M |
| 477 | PBYI | Puma Biotechnology, Inc. | 506.91M | 2.40% | 360,587 | 231.24M |
| 478 | NPCE | NeuroPace, Inc. | 504.91M | 1.17% | 160,484 | 106.99M |
| 479 | MCTA | Charming Medical Limited | 504.26M | -0.85% | - | 4.81M |
| 480 | CTNM | Contineum Therapeutics, Inc. | 504.12M | -1.11% | 770,221 | - |
| 481 | KMDA | Kamada Ltd. | 503.69M | 1.49% | 125,838 | 191.85M |
| 482 | PRLD | Prelude Therapeutics Incorporated | 499.53M | 3.19% | 421,262 | 22.42M |
| 483 | CTEV | Claritev Corporation | 499.10M | -6.86% | 176,428 | 994.67M |
| 484 | EIKN | Eikon Therapeutics, Inc. | 486.40M | 1.70% | 430,660 | - |
| 485 | SRTA | Strata Critical Medical, Inc. | 484.80M | 1.48% | 666,231 | 255.98M |
| 486 | NRC | NRC Health | 483.53M | 2.77% | 131,030 | 140.00M |
| 487 | CLPT | ClearPoint Neuro, Inc. | 481.66M | 13.03% | 1,144,027 | 42.28M |
| 488 | SGHT | Sight Sciences, Inc. | 473.21M | 1.18% | 213,395 | 83.38M |
| 489 | TKNO | Alpha Teknova, Inc. | 470.85M | 5.16% | 492,030 | 43.70M |
| 490 | KYTX | Kyverna Therapeutics, Inc. | 464.44M | 5.48% | 836,799 | - |
| 491 | MASS | 908 Devices Inc. | 462.11M | 2.76% | 424,218 | 60.84M |
| 492 | PRTA | Prothena Corporation plc | 461.52M | 5.64% | 442,524 | 54.53M |
| 493 | PACB | Pacific Biosciences of California, Inc. | 456.92M | 8.09% | 7,848,551 | 159.27M |
| 494 | TTRX | Turn Therapeutics Inc. | 455.46M | -0.33% | 122,647 | - |
| 495 | AVIR | Atea Pharmaceuticals, Inc. | 452.35M | 3.87% | 237,508 | - |
| 496 | RLMD | Relmada Therapeutics, Inc. | 452.28M | 1.92% | 660,575 | - |
| 497 | EDIT | Editas Medicine, Inc. | 448.45M | 3.18% | 2,294,624 | 47.01M |
| 498 | SPRY | ARS Pharmaceuticals, Inc. | 445.52M | 2.99% | 1,258,471 | 116.93M |
| 499 | ZURA | Zura Bio Limited | 432.19M | 0.22% | 2,150,458 | - |
| 500 | EVH | Evolent Health, Inc. | 429.63M | 2.98% | 1,534,839 | 2.10B |